Results 81 to 90 of about 34,587 (240)

Cancer Risk in Marfan Syndrome: A Swedish Population‐Based Cohort Study

open access: yesInternational Journal of Cancer, Volume 159, Issue 7, Page 1707-1714, 1 October 2026.
The cancer risk in Marfan syndrome, an autosomal dominant connective tissue disorder, largely remains to be explored. In this population‐based matched cohort study of 1544 Swedish patients, the overall cancer risk in adults with Marfan syndrome showed no significant increase, except for the risk of endocrine tumours with a nearly threefold increase ...
Ida Nordgren   +8 more
wiley   +1 more source

Medullary thyroid cancer (MTC): Risk Factors for Recurrence and Prognostic Variables that Influence Outcome

open access: yesSVU - International Journal of Medical Sciences
Background: Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor from thyroid C cells that can cause thyroid lumps or metastases. MTC accounts for 10.5% of metastasized thyroid tumors and is linked to RET proto-oncogene mutations.
Ayman A. Amin   +3 more
doaj   +1 more source

The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change

open access: yesInternational Journal of Cancer, Volume 159, Issue 7, Page 1588-1601, 1 October 2026.
ABSTRACT The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s.
James D. Brierley   +8 more
wiley   +1 more source

Diagnostic potential of B‐cell translocation gene 2 in IgA nephropathy: Insights from molecular mechanisms

open access: yesJournal of Cell Communication and Signaling, Volume 20, Issue 3, September 2026.
Diagnostic value of BTG2 and its immunoregulatory mechanism in IgAN. This study reveals that BTG2 improves immune microenvironment dysregulation, attenuates inflammation, and reduces fibrosis by promoting the expansion of T follicular helper cells, inducing macrophage polarization toward an M2 anti‐inflammatory phenotype, and inhibiting the TGF‐β1 ...
Min Kou   +4 more
wiley   +1 more source

Uncommon metastatic journey: unusual breast metastases of medullary thyroid carcinoma: a case report

open access: yesBMC Women's Health
Medullary thyroid carcinoma is a neuroendocrine tumor derived from thyroid C-cells. It is a rare aggressive tumor, known to metastasize to lymph nodes, liver, bones, and lungs.
Saadallah Fatma   +7 more
doaj   +1 more source

Kinase inhibitors in thyroid cancers

open access: yesEndocrine Oncology
Objective: The treatment landscape for thyroid cancers has changed rapidly with the availability of kinase inhibitors against VEGFR, BRAF, MEK, NTRK, and RET.
Vineeth Sukrithan   +3 more
doaj   +1 more source

Supplementary Tables S1-S4 and Supplementary Figures S1-S12 from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca<sup>2+</sup>, FOS, and Autophagy-Dependent Pathways

open access: gold, 2023
Marika H. Tesselaar   +10 more
openalex   +1 more source

Knowledge gaps in tubular gut tumours: a critical appraisal of the 6th edition of the World Health Organization classification of tumours

open access: yesThe Journal of Pathology, Volume 270, Issue 1, Page 4-22, September 2026.
Abstract Gastrointestinal cancer is a global health problem. In the new 6th edition of the World Health Organization Classification of Tumours (WCT) of the Digestive System, updated evidence and guidance is provided for the aetiology, pathogenesis, diagnosis, classification, grading, staging and prognosis of these tumours.
Iris D Nagtegaal   +5 more
wiley   +1 more source

Dual Inhibition of RET and FGFR4 Restrains Medullary Thyroid Cancer Cell Growth [PDF]

open access: bronze, 2005
Shereen Ezzat   +3 more
openalex   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

open access: yes
World Journal of Surgery, EarlyView.
Matilda Anneback   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy